LA
OCEA

Linden Advisors’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Linden Advisors’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-78,602
Closed -$817K – 488
2022
Q4 		$817K Hold
78,602
– – 0.01% 320
2022
Q3 		$800K Hold
78,602
– – 0.01% 386
2022
Q2 		$797K Hold
78,602
– – 0.01% 420
2022
Q1 		$792K Hold
78,602
– – 0.01% 494
2021
Q4 		$786K Buy
+78,602
New +$785K ﹤0.01% 509

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
CCFM
Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AI
Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Linden Advisors's OCEA Position: Q1 2023 in Review

Linden Advisors sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q1 2023, closing a stake of 78,602 shares — an estimated $817K sold.

Linden Advisors first reported a position in OCEA in Q4 2021 and held it in 5 quarters. The position peaked at $817K in Q4 2022. 17 funds tracked by Wall St. Rank hold OCEA as of Q1 2023.

  • Linden Advisors reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Linden Advisors sold 78,602 Ocean Biomedical, Inc. Common Stock shares in Q1 2023, an estimated $817K.
  • Linden Advisors first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Linden Advisors's Ocean Biomedical, Inc. Common Stock position peaked at $817K in Q4 2022.
  • 17 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q1 2023.

Based on Linden Advisors's 13F filing for Q1 2023, filed 15 May 2023.